Vimarsana
Biggest News Aggregation in the World

Rare Disease Program News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Rare Disease Program. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Rare Disease Program Today - Breaking & Trending Today

People were taking many steps towards making Cystic Fibrosis history - Vimarsana News

People were taking many steps towards making Cystic Fibrosis history

The Walk to Make Cystic Fibrosis History had a big day in its 9th edition raising almost $40,000.

Paratek Pharmaceuticals Announces Full-Year 2022 Revenue of $160.3 Million - Vimarsana News

Paratek Pharmaceuticals Announces Full-Year 2022 Revenue of $160.3 Million

16.03.2023 - - NUZYRA (omadacycline) Generated Net U.S. Sales of $98.7 Million from the Core Commercial Business, a 45% Increase Over the Prior Year - Continued Progress on the Rare Disease Nontuberculous Mycobacteria (NTM) & BARDA Project BioShield Anthrax ...

Capital Region parents push for FDA reform of rare disease drug reviews - Vimarsana News

Capital Region parents push for FDA reform of rare disease drug reviews

Capital Region parents push for FDA reform of rare disease drug reviews Federal legislation would require rare disease experts, patients weigh in when drugs come up for review FacebookTwitterEmail U.S. Rep. Paul Tonko, D-NY, holds a virtual discussion on legislation he says would strengthen the FDA review process for approving rare disease treatments.Screenshot Capital Region parents are helping lead the push for bipartisan federal legislation that advocates say would lead to better, easier and more affordable treatment for rare diseases. The parents, all of whom have children in the area wit...